Tugay Avcı

5PUBLICATIONS
24CO-AUTHORS
Molecular targetsInnate immunityWomen's studies (incl. girls' studies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 12, 2026
Nephrotoxicity secondary to CDK 4/6 inhibitors in advanced breast cancer patients and its impact on survival.

Tugay Avci, Ahmet Anil Altunbas, Mustafa Sahbazlar

|Nov 27, 2025
The Advanced Lung Cancer Inflammation Index: A Powerful and Independent Prognostic Factor in Metastatic Gastric Cancer.

Tugay Avci, Mustafa Sahbazlar, Ferhat Ekinci

|Sep 03, 2025
Comparison of the efficacy of mFOLFOX-6 and mDCF regimens in the treatment of metastatic gastric cancer: a multicenter retrospective study.

Ogur Karhan, Serdar İleri, Zuhat Urakçı

|Mar 26, 2025
Real-Life Efficacy of Palbociclib and Ribociclib in Advanced Breast Cancer.

Tugay Avci, Mustafa Sahbazlar, Ferhat Ekinci

Pageof 1